pubs.acs.org/joc
Enantioselective Synthesis of Indole-Fused
Dihydropyranones via Catalytic Cycloaddition of
Ketenes and 3-Alkylenyloxindoles
Hui Lv, Xiang-Yu Chen, Li-hui Sun, and Song Ye*
CAS Key Laboratory of Molecular Recognition and Function,
Beijing National Laboratory for Molecular Sciences, Institute
of Chemistry, Chinese Academy of Sciences, Beijing 100190,
People’s Republic of China
FIGURE 1. Indole-fused dihydropyranones.
biologically active natural products and pharmaceutical
agents.2 Consequently, great efforts have been devoted to
the synthesis of various fused indoles, and many efficient
approaches have been documented.3 In the meantime, dihydro-
pyranones also present a wide range of biologically active
compounds.4 Thus a hybrid of these two motifs could poten-
tially lead to a series of structurally and biologically interesting
compounds (Figure 1). Although the synthesis and application
of indole-fused pyranones and their derivatives have been
reported sporadically,5 to the best of our knowledge, the direct
asymmetric synthesis of these compounds remains a challenge.
N-Heterocyclic carbenes (NHCs) are useful reagents for
synthesis of heterocyclic compounds,6 excellent ligands for
organometallic catalysts,7 and versatile organocatalysts for
varied reactions.8,9 In this context, we, simultaneously with
Received July 5, 2010
(5) (a) Bestmann, H. J.; Schmid, G. Tetrahedron Lett. 1984, 25, 1441.
(b) Ohnuma, T.; Kasuya, H.; Kimura, Y.; Ban, Y. Heterocycles 1982, 17, 377.
(c) Amiet, R. G.; Eastwood, F. W.; Rae, I. D. R. Aust. J. Chem. 1972, 25,
1473. (d) Nakagawa, M.; Sodeoka, M.; Yamaguchi, K.; Hino, T. Chem.
Pharm. Bull. 1984, 32, 1373. (e) Fritz, H.; Losacker, P. Justus Liebigs Ann.
Chem. 1967, 709, 135. (f ) Feldman, K. S.; Karatjas, A. G. Org. Lett. 2004, 6,
2849. (g) Kam, T. S.; Tan, S. J.; Ng, S. W.; Komiyama, K. Org. Lett. 2008, 10,
3749. Feldman, K. S.; Vidulova, D. B.; Karatjas, A. D. J. Org. Chem. 2005,
70, 6429. (h) Reh, S.; Bergman, J. Tetrahedron 2005, 61, 3115.
(6) (a) Bourissou, D.; Guerret, O.; Gabbaı, F. P.; Bertrand, G. Chem. Rev.
2000, 100, 39. (b) Cheng, Y.; Meth-Cohn, O. Chem. Rev. 2004, 104, 2507.
(c) Cheng, Y.; Wang, B.; Wang, X.-R.; Zhang, J.-H.; Fang, D.-C. J. Org.
Chem. 2009, 74, 2357. (d) Cheng, Y.; Peng, J. H.; Li, J. Q. J. Org. Chem. 2010,
75, 2382. (e) Cheng, Y.; Liu, M.-F; Fang; Lei, X.-M. Chem.;Eur. J. 2007, 13,
4282. (f ) Ding, H. F.; Zhang, Y. P.; Bian, M.; Yao, W. J.; Ma, C. J. Org.
Chem. 2008, 73, 578. (g) Ma, C.; Yang, Y. W. Org. Lett. 2005, 7, 1343.
(h) Nair, V.; Bindu, S.; Sreekumar, V.; Rath, N. P. Org. Lett. 2003, 5, 665.
(7) (a) N-Heterocyclic Carbenes in Transition Metal Catalysis; Glorius,
F., Ed.; Topics in Organometallic Chemistry, Vol. 28; Springer-Verlag:
Berlin, 2007. (b) N-Heterocyclic Carbenes in Synthesis; Nolan, S. P., Ed.;
Wiley-VCH: Weinheim, 2006.
Chiral N-heterocyclic carbenes were found to be efficient
catalysts for the formal [4þ2] cycloaddition reaction of
alkyl(aryl)ketenes and 3-alkylenyloxindoles to give the corre-
sponding 3,4-dihydropyrano[2,3-b]indol-2-ones in excel-
lent yields with good diastereo- and enantioselectivities.
Convenient methods for constructing molecules with two
separate biologically interesting scaffolds that are fused are
of great value for both organic and medicinal chemists.1 The
indole ring is regarded as a privileged structure in many
(1) (a) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103,
893. (b) Gil, C.; Brase, S. J. Comb. Chem. 2009, 11, 175.
(8) For reviews, see: (a) Enders, D.; Niemeier, O.; Henseler, A. Chem.
Rev. 2007, 107, 5606. (b) Marion, N.; Diez-Gonzalez, S.; Nolan, S. P. Angew.
Chem., Int. Ed. 2007, 46, 2988. (c) Enders, D.; Balensiefer, T. Acc. Chem. Res.
2004, 37, 534.
(2) For reviews, see: (a) Humphrey, G. R.; Kuethe, J. T. Chem. Rev. 2006,
106, 2875. (b) Gribble, G. W. J. Chem. Soc., Perkin Trans. 1 2000, 1045.
(c) Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 105, 2873. (d) Saki, N.; Annaka,
K.; Fujita, A.; Sato, A. J. Org. Chem. 2008, 73, 4160. (e) Bandini, M.;
Eichholzer, A. Angew. Chem. In. Ed. 2009, 48, 9608.
(9) (a) Ugai, T.; Tanaka, S.; Dokawa, S. J. Pharm. Soc. Jpn. 1943, 63, 296.
( Chem. Abstr. 1951, 45, 5148). (b) Breslow, R. J. Am. Chem. Soc. 1958, 80,
3119. (c) Stetter, H.; Schreckenberg, M. Angew. Chem. 1973, 85, 89. Angew.
Chem., Int. Ed. 1973, 12, 81. (d) Burstein, C.; Glorius, F. Angew. Chem., Int.
Ed. 2004, 43, 6205. (e) Sohn, S. S.; Rosen, E. L.; Bode, J. W. J. Am. Chem.
Soc. 2004, 126, 14370. (f ) Reynolds, N. T.; de Alaniz, J. R.; Rovis, T. J. Am.
Chem. Soc. 2004, 126, 9518. (g) Fischer, C.; Smith, S. W.; Powell, D. A.; Fu,
G. C. J. Am. Chem. Soc. 2006, 128, 1472. (h) He, L.; Jian, T.-Y.; Ye, S. J. Org.
Chem. 2007, 72, 7466. (i) Du, D.; Wang, Z. Eur. J. Org. Chem. 2008, 4949.
( j) Li, G.-Q.; Li, Y.; Dai, L.-X.; You, S.-L. Adv. Synth. Catal. 2008, 350,
1258. (k) Rommel, M.; Fukuzumi, T.; Bode, J. W. J. Am. Chem. Soc. 2008,
130, 17266. (l) Chan, A.; Scheidt, K. A. J. Am. Chem. Soc. 2007, 129, 5334.
(m) Chan, A.; Scheidt, K. A. J. Am. Chem. Soc. 2008, 130, 2740. (n) Vora,
H. U.; Rovis, T. J. Am. Chem. Soc. 2010, 132, 2680. (o) Nair, V.; Vellalath, S.;
Poonoth, M.; Mohan, R.; Suresh, E. Org. Lett. 2006, 8, 507. (p) Biju, A. T.;
Wurz, N. E.; Glorius, F. J. Am. Chem. Soc. 2010, 132, 5970. (q) Enders, D.;
Henseler, A. Adv. Synth. Catal. 2009, 351. (r) Ye, W.; Cai, G.; Zhuang, Z.;
Jia, X.; Zhai, H. Org. Lett. 2005, 7, 3769. (s) Liu, Y. K.; Li, R.; Yue, L.; Li,
B. J.; Chen, Y. C.; Wu, Y.; Ding, L. S. Org. Lett. 2006, 8, 1521. (t) Sun, X. Y.;
Ye, S. Q.; Wu, J. Eur. J. Org. Chem. 2006, 4787.
(3) For examples, see: (a) Pudlo, M.; Csanyi, D.; Moreau, F.; Riedl, Z.;
Sapi, J. Tetrahedron 2007, 63, 10320. (b) Majumdar, K. C.; Taher, A.; Ponra,
S. Tetrahedron Lett. 2010, 51, 147. (c) Barluenga, J.; Tudela, E.; Ballesteros,
A.; Tomas, M. J. Am. Chem. Soc. 2009, 131, 2096. (d) Singh, V.; Hutait, S.;
Biswas, S.; Batra, S. Eur. J. Org. Chem. 2010, 531. (e) John, J.; Indu, U.;
Suresh, E.; Radhakrishnan, K. V. J. Am. Chem. Soc. 2009, 131, 5042.
(f ) Fillion, E.; Dumas, A. M. J. Org. Chem. 2008, 73, 2920. (g) Li, G. J.;
Wang, E.; Chen, H.; Li, H. F.; Liu, Y. H.; Wang, P. G. Tetrahedron 2008, 64,
9033. (h) Halim, R.; Scammells, P. G.; Flynn, B. Org. Lett. 2008, 10, 1967.
(4) (a) Hamilton, H. W.; Tait, B. D.; Gajda, C.; Hagen, S. E.; Ferguson,
D.; Lunney, E. A.; Pavlovsky, A.; Tummino., P. J. Bioorg. Med. Chem. Lett.
1996, 6, 719. (b) Krishna, P. R.; Srinivas, R. Tetrahedron: Asymmetry 2007,
18, 2197. (c) Narasimhulu, M.; Krishna, A. S.; Rao, J. R.; Venkateswarlu, Y.
ꢀ
Tetrahedron 2009, 15, 2989. (d) Kasaplar, P.; Yilmazer, O.; Cagir, A. Bioorg.
Med. Chem. 2009, 1, 311. (e) Mohapatra, D. K.; Das, P. P.; Reddy, D. S.;
Yadav, J. S. Tetrahedron Lett. 2009, 43, 5941. (f ) Krishna, P. R.; Srinivas, R.
Tetrahedron Lett. 2007, 48, 2013. (g) Das, B.; Laxminarayana, K.; Krishnaiah,
M.; Kumar, D. N. Bioorg. Med. Chem. Lett. 2009, 22, 6396.
DOI: 10.1021/jo101318u
r
Published on Web 09/15/2010
J. Org. Chem. 2010, 75, 6973–6976 6973
2010 American Chemical Society